These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma. Arora M; Mane DR J Oral Maxillofac Pathol; 2018; 22(2):279-280. PubMed ID: 30158786 [TBL] [Abstract][Full Text] [Related]
3. EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival. Monteiro LS; Delgado ML; Ricardo S; Garcez F; do Amaral B; Pacheco JJ; Lopes C; Bousbaa H Biomed Res Int; 2014; 2014():905680. PubMed ID: 24967412 [TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinase-9 in histological grades of oral squamous cell carcinoma: An immunohistochemical study. Patil R; Mahajan A; Pradeep GL; Prakash N; Patil S; Khan SM J Oral Maxillofac Pathol; 2021; 25(2):239-246. PubMed ID: 34703116 [TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of EGFR and EMMPRIN in a series of cases of head and neck squamous cell carcinoma. de Andrade AL; Ferreira SJ; Ferreira SM; Ribeiro CM; Freitas Rde A; Galvão HC Pathol Res Pract; 2015 Oct; 211(10):776-81. PubMed ID: 26296920 [TBL] [Abstract][Full Text] [Related]
6. Expression of extracellular matrix metalloproteinase inducer and fascin in urinary bladder cancer: Correlation with clinicopathological characteristics. El-Rehim DM; El-Maqsoud NM; El-Hamid AM; El-Bab TK; Galal EM Mol Clin Oncol; 2013 Mar; 1(2):297-304. PubMed ID: 24649164 [TBL] [Abstract][Full Text] [Related]
7. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. Erdem NF; Carlson ER; Gerard DA; Ichiki AT J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389 [TBL] [Abstract][Full Text] [Related]
8. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069 [TBL] [Abstract][Full Text] [Related]
9. EMMPRIN expression in tongue squamous cell carcinoma. Huang Z; Huang H; Li H; Chen W; Pan C J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis. Huang Z; Tan N; Guo W; Wang L; Li H; Zhang T; Liu X; Xu Q; Li J; Guo Z PLoS One; 2014; 9(4):e91596. PubMed ID: 24705283 [TBL] [Abstract][Full Text] [Related]
11. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters. Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma. Chu T; Chen X; Yu J; Xiao J; Fu Z Pathol Oncol Res; 2011 Sep; 17(3):705-11. PubMed ID: 21448785 [TBL] [Abstract][Full Text] [Related]
13. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma. Cao Z; Xiang J; Li C Int J Oral Maxillofac Surg; 2009 Aug; 38(8):880-5. PubMed ID: 19372030 [TBL] [Abstract][Full Text] [Related]
14. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma. Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016 [TBL] [Abstract][Full Text] [Related]
15. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions. Varadarajan S; Balaji TM; Sarode SC; Sarode GS; Sharma NK; Gondivkar S; Gadbail A; Patil S Med Hypotheses; 2020 Oct; 143():110089. PubMed ID: 32673940 [TBL] [Abstract][Full Text] [Related]
16. [Expression of matrix metalloproteinase (MMP-2) and extracellular matrix metalloproteinases inducer (EMMPRIN) in benign and advanced breast cancer tissue samples]. Chandru H; Sharada AC; Manjunath S Biomed Khim; 2007; 53(4):461-7. PubMed ID: 18035727 [TBL] [Abstract][Full Text] [Related]